UPDATE: Click here to order samples for your practice.
Confidently manage your patients’ post-cataract
care with PROLENSA®
*IQVIA NPA Monthly. July 2020
Most eligible patients may pay no more than†:
Medicare Part D
*MMIT data 2020.
†Terms, conditions and limitations apply. Please see www.bauschaccessprogram.com or www.prolensapartdcoupon.com for eligible criteria and terms and conditions.
Direct patients to www.bauschaccessprogram.com where they can activate a printed coupon or download a digital coupon, and review eligibility terms and conditions*.
Print coupons can also be activated by calling 1-866-693-4880.
Bausch + Lomb has aligned with Walgreens to stock product and help eligible patients redeem prescription savings on our products.
Contact your sales representative to provide in-office printed coupons.
If you have any questions regarding your eligibility or benefits, please call 1-866-693-4880.
*Terms and conditions apply. Please see www.bauschaccessprogram.com for eligibility criteria and terms and conditions
The PROLENSA Part D Program offers savings for Medicare Part D patients. Most eligible patients pay no more than $60 co-pay on their PROLENSA® prescription†.
Patients can activate the print coupon by calling 1-866-686-0091. To activate the online download coupon, patients must agree to the statements on www.prolensapartdcoupon.com.
Patients can redeem the coupon card at a participating retail pharmacy with their prescription and insurance cards.
Make sure patients sign and mail the prewritten letter, which notifies the health plan of their choice to use the benefits of this program. Healthcare plan address can be found on the Medicare provider card.
Contact your sales representative to receive in-office printed coupons. If you have questions related to this program, please call 1-866-686-0091.
†Terms, conditions and limitations apply. Please see www.prolensapartdcoupon.com for eligibility criteria and terms and conditions.
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Clickhere for full Prescribing Information for PROLENSA®.